Erratum: Tauroursodeoxycholic acid prevents retinal degeneration in transgenic P23H rats (Invest Ophthalmol Vis Sci., (2011) 52,(4998-5008), 10.1167/iovs.11-7496);Tauroursodeoxycholic acid prevents retinal degeneration in transgenic P23H rats

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 8, 2011, Pages 4998-5008

  Fernández Sánchez, Laura ^a   Lax, Pedro ^a   Pinilla, Isabel ^b   Martín Nieto, José ^a   Cuenca, Nicolás ^a  

^a UNIVERSITY OF ALICANTE   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

TAUROURSODEOXYCHOLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTRORETINOGRAM; NEUROPROTECTION; NIGHT VISION; NONHUMAN; PHOTOPIC VISION; PHOTORECEPTOR; PRIORITY JOURNAL; RAT; RETINA; RETINA BIPOLAR GANGLION CELL; RETINA CONE; RETINA DEGENERATION; RETINA HORIZONTAL NERVE CELL; RETINA OUTER MOLECULAR LAYER; RETINA ROD; RETINITIS PIGMENTOSA; SYNAPSE;

EID: 79960064834     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-7496a     Document Type: Erratum

References (65)

1. Dryja TP, McGee TL, Reichel E, et al. A point mutation of the rhodopsin gene in one form of retinitis pigmentosa. Nature. 1990; 343:364-366.
2. Dryja TP, McEvoy JA, McGee TL, Berson EL. Novel rhodopsin mutations Gly114Val and Gln184Pro in dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2000;41:3124-3127.
3. Kaushal S, Khorana HG. Structure and function in rhodopsin, 7: point mutations associated with autosomal dominant retinitis pigmentosa. Biochemistry. 1994;33:6121-6128.
4. Illing ME, Rajan RS, Bence NF, Kopito RR. A rhodopsin mutant linked to autosomal dominant retinitis pigmentosa is prone to aggregate and interacts with the ubiquitin proteasome system. J Biol Chem. 2002;277:34150-34160.
5. Reme CE, Grimm C, Hafezi F, Marti A, Wenzel A. Apoptotic cell death in retinal degenerations. Prog Retin Eye Res. 1998;17:443-464.
6. Musarella MA, Macdonald IM. Current concepts in the treatment of retinitis pigmentosa. J Ophthalmol. 2011;2011:753547 [Epub 2010 Oct 11]. In press.
7. Chadderton N, Millington-Ward S, Palfi A, et al. Improved retinal function in a mouse model of dominant retinitis pigmentosa following AAV-delivered gene therapy. Mol Ther. 2009;17:593-599.
8. Palfi A, Millington-Ward S, Chadderton N, et al. Adeno-associated virus-mediated rhodopsin replacement provides therapeutic benefit in mice with a targeted disruption of the rhodopsin gene. Hum Gene Ther. 2010;21:311-323.
9. Pang JJ, Dai X, Boye SE, et al. Long-term retinal function and structure rescue using capsid mutant AAV8 vector in the rd10 mouse, a model of recessive retinitis pigmentosa. Mol Ther. 2010; 19:234-242.
10. Millington-Ward S, Chadderton N, O'Reilly M, et al. Suppression and replacement gene therapy for autosomal dominant disease in a murine model of dominant retinitis pigmentosa. Mol Ther. 2011; 19:642-649.
11. Stieger K. TgAAG76, an adeno-associated virus delivered gene therapy for the potential treatment of vision loss caused by RPE65 gene abnormalities. Curr Opin Mol Ther. 2010;12:471-477.
12. Farrar GJ, Palfi A, O'Reilly M. Gene therapeutic approaches for dominant retinopathies. Curr Gene Ther. 2010;10:381-388.
13. Boatright JH, Moring AG, McElroy C, et al. Tool from ancient pharmacopoeia prevents vision loss. Mol Vis. 2006;12:1706-1714.
14. Phillips MJ, Walker TA, Choi HY, et al. Tauroursodeoxycholic acid preservation of photoreceptor structure and function in the rd10 mouse through postnatal day 30. Invest Ophthalmol Vis Sci. 2008; 49:2148-2155.
15. Boatright JH, Nickerson JM, Moring AG, Pardue MT. Bile acids in treatment of ocular disease. J Ocul Biol Dis Infor. 2009;2:149-159.
16. Oveson BC, Iwase T, Hackett SF, et al. Constituents of bile, bilirubin and TUDCA, protect against oxidative stress-induced retinal degeneration. J Neurochem. 2011;116:144-153.
17. Keene CD, Rodrigues CM, Eich T, Chhabra MS, Steer CJ, Low WC. Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease. Proc Natl Acad Sci U S A. 2002;99:10671-10676.
18. Duan WM, Rodrigues CM, Zhao LR, Steer CJ, Low WC. Tauroursodeoxycholic acid improves the survival and function of nigral transplants in a rat model of Parkinson's disease. Cell Transplant. 2002;11:195-205.
19. Viana RJ, Nunes AF, Castro RE, et al. Tauroursodeoxycholic acid prevents E22Q Alzheimer's Abeta toxicity in human cerebral endothelial cells. Cell Mol Life Sci. 2009;66:1094-1104.
20. Cuenca N, Pinilla I, Sauvé Y, Lu B, Wang S, Lund RD. Regressive and reactive changes in the connectivity patterns of rod and cone pathways of P23H transgenic rat retina. Neuroscience. 2004;127: 301-317.
21. Pinilla I, Lund RD, Sauvé Y. Enhanced cone dysfunction in rats homozygous for the P23H rhodopsin mutation. Neurosci Lett. 2005;382:16-21.
22. Cuenca N, De Juan J, Kolb H. Substance P-immunoreactive neurons in the human retina. J Comp Neurol. 1995;356:491-504.
23. Cuenca N, Kolb H. Circuitry and role of substance P-immunoreactive neurons in the primate retina. J Comp Neurol. 1998; 393:439-456.
24. Cuenca N, Herrero MT, Angulo A, et al. Morphological impairments in retinal neurons of the scotopic visual pathway in a monkey model of Parkinson's disease. J Comp Neurol. 2005;493: 261-273.
25. Cuenca N, Pinilla I, Sauvé Y, Lund R. Early changes in synaptic connectivity following progressive photoreceptor degeneration in RCS rats. Eur J Neurosci. 2005;22:1057-1072.
26. Barhoum R, Martínez-Navarrete G, Corrochano S, et al. Functional and structural modifications during retinal degeneration in the rd10 mouse. Neuroscience. 2008;155:698-713.
27. Johnson JE Jr, Perkins GA, Giddabasappa A, et al. Spatiotemporal regulation of ATP and Ca2 dynamics in vertebrate rod and cone ribbon synapses. Mol Vis. 2007;13:887-919.
28. Pinilla I, Cuenca N, Martínez-Navarrete G, Lund RD, Sauvé Y. Intraretinal processing following photoreceptor rescue by nonretinal cells. Vision Res. 2009;49:2067-2077.
29. Pinilla I, Cuenca N, Sauvé Y, Wang S, Lund RD. Preservation of outer retina and its synaptic connectivity following subretinal injections of human RPE cells in the Royal College of Surgeons rat. Exp Eye Res. 2007;85:381-392.
30. McGinnis JF, Stepanik PL, Chen W, Elias R, Cao W, Lerious V. Unique retina cell phenotypes revealed by immunological analysis of recoverin expression in rat retina cells. J Neurosci Res. 1999; 55:252-260.
31. Martínez-Navarrete GC, Martín-Nieto J, Esteve-Rudd J, Angulo A, Cuenca N. Alpha synuclein gene expression profile in the retina of vertebrates. Mol Vis. 2007;13:949-961.
32. Zhang L, Fina ME, Vardi N. Regulation of KCC2 and NKCC during development: membrane insertion and differences between cell types. J Comp Neurol. 2006;499:132-143.
33. Cuenca N, Pinilla I, Fernández-Sánchez L, et al. Changes in the inner and outer retinal layers after acute increase of the intraocular pressure in adult albino Swiss mice. Exp Eye Res. 2010;91:273-285.
34. Rubenstein JL, Greengard P, Czernik AJ. Calcium-dependent serine phosphorylation of synaptophysin. Synapse. 1993;13: 161-172.
35. Stocker R, Glazer AN, Ames BN. Antioxidant activity of albuminbound bilirubin. Proc Natl Acad Sci U S A. 1987;84:5918-5922.
36. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science. 1987;235:1043-1046.
37. Ishizaka N, Ishizaka Y, Takahashi E, Yamakado M, Hashimoto H. High serum bilirubin level is inversely associated with the presence of carotid plaque. Stroke. 2001;32:580-583.
38. Vitek L, Jirsa M, Brodanova M, et al. Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis. 2002;160:449-456.
39. Djousse L, Rothman KJ, Cupples LA, Levy D, Ellison RC. Effect of serum albumin and bilirubin on the risk of myocardial infarction (the Framingham Offspring Study). Am J Cardiol. 2003;91:485-488.
40. Novotny L, Vitek L. Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies. Exp Biol Med (Maywood). 2003;228:568-571.
41. Machida S, Kondo M, Jamison JA, et al. P23H rhodopsin transgenic rat: correlation of retinal function with histopathology. Invest Ophthalmol Vis Sci. 2000;41:3200-3209.
42. García-Ayuso D, Salinas-Navarro M, Agudo M, et al. Retinal ganglion cell numbers and delayed retinal ganglion cell death in the P23H rat retina. Exp Eye Res. 2010;91:800-810.
43. Kolomiets B, Dubus E, Simonutti M, Rosolen S, Sahel JA, Picaud S. Late histological and functional changes in the P23H rat retina after photoreceptor loss. Neurobiol Dis. 2010;38:47-58.
44. Berson EL, Rosner B, Sandberg MA, Dryja TP. Ocular findings in patients with autosomal dominant retinitis pigmentosa and a rhodopsin gene defect (Pro-23-His). Arch Ophthalmol. 1991;109:92-101.
45. Lax P, Otalora BB, Esquiva G, Rol Mde L, Madrid JA, Cuenca N. Circadian dysfunction in P23H rhodopsin transgenic rats: effects of exogenous melatonin. J Pineal Res. 2011;50:183-191.
46. Chang B, Hawes NL, Hurd RE, Davisson MT, Nusinowitz S, Heckenlively JR. Retinal degeneration mutants in the mouse. Vision Res.2002;42:517-525.
47. Gargini C, Terzibasi E, Mazzoni F, Strettoi E. Retinal organization in the retinal degeneration 10 (rd10) mutant mouse: a morphological and ERG study. J Comp Neurol. 2007;500:222-238.
48. Usui S, Komeima K, Lee SY, et al. Increased expression of catalase and superoxide dismutase 2 reduces cone cell death in retinitis pigmentosa. Mol Ther. 2009;17:778-786.
49. Komeima K, Usui S, Shen J, Rogers BS, Campochiaro PA. Blockade of neuronal nitric oxide synthase reduces cone cell death in a model of retinitis pigmentosa. Free Radic Biol Med. 2008;45:905-912.
50. Xie Q, Khaoustov VI, Chung CC, et al. Effect of tauroursodeoxycholic acid on endoplasmic reticulum stress-induced caspase-12 activation. Hepatology. 2002;36:592-601.
51. Wang X. The expanding role of mitochondria in apoptosis. Genes Dev. 2001;15:2922-2933.
52. Szikra T, Krizaj D. Intracellular organelles and calcium homeostasis in rods and cones. Vis Neurosci. 2007;24:733-743.
53. Dauer W, Przedborski S. Parkinson's disease: mechanisms and models. Neuron. 2003;39:889-909.
54. Vila M, Przedborski S. Targeting programmed cell death in neurodegenerative diseases. Nat Rev Neurosci. 2003;4:365-375.
55. Yadava N, Nicholls DG. Spare respiratory capacity rather than oxidative stress regulates glutamate excitotoxicity after partial respiratory inhibition of mitochondrial complex I with rotenone. J Neurosci. 2007;27:7310-7317.
56. Nicholls DG, Johnson-Cadwell L, Vesce S, Jekabsons M, Yadava N. Bioenergetics of mitochondria in cultured neurons and their role in glutamate excitotoxicity. J Neurosci Res. 2007;85:3206-3212.
57. Rodrigues CM, Sola S, Sharpe JC, Moura JJ, Steer CJ. Tauroursodeoxycholic acid prevents Bax-induced membrane perturbation and cytochrome c release in isolated mitochondria. Biochemistry. 2003;42:3070-3080.
58. Kageyama GH, Wong-Riley MT. The histochemical localization of cytochrome oxidase in the retina and lateral geniculate nucleus of the ferret, cat, and monkey, with particular reference to retinal mosaics and ON/OFF-center visual channels. J Neurosci. 1984;4: 2445-2459.
59. Hamel C. Retinitis pigmentosa. Orphanet J Rare Dis. 2006;1:40.
60. Berson EL, Rosner B, Sandberg MA, et al. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol. 1993;111:761-772.
61. Bowne SJ, Sullivan LS, Blanton SH, et al. Mutations in the inosine monophosphate dehydrogenase 1 gene (IMPDH1) cause the RP10 form of autosomal dominant retinitis pigmentosa. Hum Mol Genet. 2002;11:559-568.
62. Huang Y, Enzmann V, Ildstad ST. Stem cell-based therapeutic applications in retinal degenerative diseases. Stem Cell Rev. 2011; 7:434-445.
63. Liang FQ, Aleman TS, Dejneka NS, et al. Long-term protection of retinal structure but not function using RAAV.CNTF in animal models of retinitis pigmentosa. Mol Ther. 2001;4:461-472.
64. Corrochano S, Barhoum R, Boya P, et al. Attenuation of vision loss and delay in apoptosis of photoreceptors induced by proinsulin in a mouse model of retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2008;49:4188-4194.
65. Liang FQ, Aleman TS, Zaixin Yang, Cideciyan AV, Jacobson SG, Bennett J. Melatonin delays photoreceptor degeneration in the rds/rds mouse. Neuroreport. 2001;12:1011-1014.